A research team based at the  Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid and Aarhus University in Denmark has identified an important mechanism that can result in the regression, or shrinkage, of atherosclerotic plaques. The study identifies cells derived from the smooth muscle cells in the arterial wall as a new target for future therapies.

These scientific gatherings have established themselves as a global reference for researchers since their first meeting in 2011.The increasing epidemic of cardiovascular disease (CVD) is attributed to the rising prevalence of modifiable cardiovascular risk factors (CVRFs). Obesity and its subsequent consequences, including cardiometabolic syndrome, are alarmingly on the rise among young people. It is evident that cognitive decline in older adults is influenced by cardiovascular health, with vascular and metabolic mechanisms proposed to underlie its etiology.